HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

vastatin

inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis; amino acid sequence in first source

Networked: 7 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Scleroproteins: 74
    - Extracellular Matrix Proteins: 3148
      - Collagen: 52417
        Non-Fibrillar Collagens: 13
        Collagen Type VIII: 40
        vastatin: 7

Experts

1.	Li, Yi: 2 articles (01/2017 - 01/2016)
2.	Lin, Marie Chia-Mi: 2 articles (01/2017 - 01/2016)
3.	Poon, Wai Sang: 2 articles (01/2017 - 01/2016)
4.	Shen, Zan: 2 articles (01/2017 - 01/2016)
5.	Yao, Hong: 2 articles (01/2017 - 01/2016)
6.	Jorgensen, Lars Nannestad: 1 article (01/2019)
7.	Karsdal, Morten Asser: 1 article (01/2019)
8.	Willumsen, Nicholas: 1 article (01/2019)
9.	Cai, Yijun: 1 article (01/2017)
10.	Li, Jun: 1 article (01/2017)

Related Diseases

1.	Hypertension (High Blood Pressure) 04/01/1998 - "Vastatin trials: lessons from hypertension history."
2.	Neoplasm Metastasis (Metastasis) 01/01/2017 - "Sustained enhanced expression of Vastatin was shown to inhibit tumour growth and metastasis in murine hepatocellular carcinoma models. " 01/01/2016 - "rAAV-Vastatin treatment significantly prolonged the median survival, inhibited tumor growth, and completely prevented metastasis in HCC-bearing rats by decreasing microvessel density and increasing tumor necrosis. " 01/01/2016 - "Erratum to "Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis"." 01/01/2016 - "Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis."
3.	Hepatocellular Carcinoma (Hepatoma) 01/01/2017 - "Sustained enhanced expression of Vastatin was shown to inhibit tumour growth and metastasis in murine hepatocellular carcinoma models. " 01/01/2016 - "Erratum to "Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis"." 01/01/2016 - "Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis."
4.	Neoplasms (Cancer) 01/01/2016 - "rAAV-Vastatin treatment significantly prolonged the median survival, inhibited tumor growth, and completely prevented metastasis in HCC-bearing rats by decreasing microvessel density and increasing tumor necrosis. " 01/01/2016 - "Erratum to "Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis"." 01/01/2016 - "Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis."
5.	Body Weight (Weight, Body) 01/01/1999 - "Each vastatin was used orally in doses of 500 mg/Kg body weight/day, in animals with a hypercholesterolemic diet (HD) 5 days, or with a control diet (CD) 30 days. " 04/01/1993 - "Young Wistar rats were weaned at an age of 21 days and had ad libitum access to a chow supplemented with 10-100 mg vastatin kg-1 (drug consumption: 1.5-15 mg vastatin kg-1 body weight day-1, respectively) or no additions for 3 weeks. "

Related Drugs and Biologics

1.	Peptides (Polypeptides)
2.	Collagen Type VIII